LEP Biomedical is developing a dissolvable implant that replaces weeks of self-administered eye drops after glaucoma surgery, aiming to fix the compliance problems that drive surgical failure rates as high as 40%.
The post This Startup Wants to Make Glaucoma Surgery Recovery Easier appeared first on MedCity News.
